There Are Reasons To Feel Uneasy About Sansure Biotech's (SHSE:688289) Returns On Capital

Simply Wall StSep 12 18:14 ET

Sansure Biotech Gets Registration Certificate for Human Gene Detection Kit

MT NewswiresSep 12 02:53 ET

sansure biotech inc. (688289.SH): Obtained the medical instruments registration certificate for the ALDH2 gene polymorphism nucleic acid detection kit.

On September 4th, Shengxiang Biotech (688289.SH) announced that the company's product, ALDH2 gene polymorphism nucleic acid detection kit (PCR-fluorescent probe method), recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The ALDH2 gene is located on the 12th chromosome of humans and encodes two isozymes, aldehyde dehydrogenase and nitrate reductase. Nitroglycerin is the most commonly used nitrate ester drug for relieving angina and expanding blood vessels, and nitrate reductase can denitrate nitroglycerin, producing nitric oxide, thereby exerting its vasodilating effect.

Gelonghui FinanceSep 4 06:24 ET

Sansure Biotech Inc.'s (SHSE:688289) Largest Shareholder, CEO Lizhong Dai Sees Holdings Value Fall by 3.4% Following Recent Drop

Simply Wall StAug 21 00:15 ET

Sansure Biotech's H1 Attributable Profit Surges 71%; Shares Fall 3%

MT NewswiresAug 20 01:48 ET

Full text of Sansure Biotech Inc.'s 2024 interim report

SZSIAug 18 12:00 ET · Announcements